(2000), The effect of processing variables on the physical ..... drug products,
handbook of pharmaceutical manufacturing formulation: Semisolid product, 4 ...
Chapter 5
References
CHAPTER: 5
References
JJT, University
Page 116
Chapter 5
References
Agarwal S et.al. (2001), Niosomal daunorubicin with reduced toxicity and improved anticancer activity in swiss mice bearing fibrosarcome, Indian Drugs, 38, p. 21-26. Andreas H et.al. (1999), High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studies, Journal of chromatography B: Biomedical Science and application, 735, p. 51-62. Arsic I (1999), Influence of liposomes on the stability of vitamin A incorporated in polyacrylate hydrogel, Int. J. Cosm. Sci., 21, p.219-225. Arunothayanum P et.al. (2000), The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from hexadecyl diglycerol ether, Int.J.Pharm, 201, p.7-14. Arvier
M
(1990),
Niosomes
d'hémoglobine.
I.
Preparation,
proprietes
physicochimiques et oxyphoriques, stabilite, Pharm Acta Helv, 65 (3), p. 82 Atiyeh B et.al. (2009), Wound cleansing, topical antiseptics and wound healing, Int Wound J, 1, p. 420–430. Azmin M et.al. (1985), The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice, J. Pharm. Pharmacol, 37, p.237–242. Babiuk S (2000), Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery, J. Control. Rel., 66, p. 199-214. Baillie A et.al. (1986) Non-ionic surfactant vesicles, niosomes, as delivery system for the anti-leishmanial drug, sodium stribogluconate, J. Pharm. Pharmacol, 38, p. 502505. Baillie A.J. et.al. (1985), The preparation and properties of niosomes-non-ionic surfactant vesicles, J. Pharm Pharmacol, 37(12), p.863–868. Beckett A and Stenlake J (1997), In: Practical pharmaceutical chemistry, CBS publishers and distributors. 4th Ed. New Delhi, 2, p. 282-307. JJT, University
Page 117
Chapter 5
References
Behl C (1980), Hydration and percutaneous absorption I. Influence of Hydration on alkanol permeation through hairless mouse skin, J. Invest. Dermatol, 75, p. 346-352. Bell G (1963), Textbook of Physiology, and Biochemistry. E & S Laivingston Publishers, Edinburgh, 5th Edition, Chapter 37, p. 29-47. Berger R, Bowman J (1982), A reappraisal of the 21 day cumulative irritation test in man, J.Toxicol.Ot.Ocular Toxicol, 1(2), p.109-115. Blazek-Walsh A. and Rhodes D (2001), SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes, Pharm. Res, 18, p. 656-661. Bonacucina G et.al. (2004), Rheological mucoadhesive and release properties of Carbopol gels in hydrophilic cosolvents, Int J Pharm, 282, p. 115–130. Bosch, William H et al. (2003), Novel triamcinolone compositions United States Patent Application 20040141925, Elan Pharma International Ltd., p. 1-25. Bousmina M. (1999), Rheology of polymer blends: Linear model for viscoelastic emulsion, Rheol Acta, 38, p.73-83. Breimer D.D. and Speiser R. (1985), Topics in pharmaceutical Sciences. 5 Elsevier Science Publishers, New York, USA. p.291. Bremecker D et.al. (1984), Nitrosamine – free polyacrylate gels: use of new type of bases for neutralization, J Pharm Sci., 73, p. 548–553. Brewer J (1992), The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin, Immunology, 75 (4), p. 570575. British Pharmacopoeia (2009), Nystatin (CAS: 1400-61-9). Monographs: Medicinal and Pharmaceutical substances, 1, p. 42. Brown M (2005), Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin, J European Acad Dermatol Venerology, 19, p. 308-318.
JJT, University
Page 118
Chapter 5
References
Brown M, Jones S (2005), Hyaluronic acid: a unique topical vehicle for the localized delivery of drug to the skin, J European Acad Dermatol Venerology, 19, p. 308- 318 Carnali J, Naser M (1992), The use of dilute solution viscosity to characterize the network properties of carbopol microgels, Colloid Polymer Science, 270, p.183–193. Cevec G (1996), Transferosomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery, Crit. Rev. Ther. Drug Carrier Sys., 13, p. 257-388. Chandraprakash K et.al. (1992), Formulation and evaluation of Methotrexate niosomes, Ind. J. Pharm. Sci, 54 (5), p. 197 Chandrashekhar G et.al. (1994), Antiinflammatory activity of Niosome encapsulated diclofenac sodium with Tween-85 in Arthitic rats, Ind. J. Pharmacol, 26, p. 46-48. Chauhan S. and Luorence M. (1989), The preparation of polyoxyethylene containing non-ionic surfactant vesicles, J. Pharm. Pharmacol, 41, p. 6. Cummings J et.al. (1984), Determination of adriamycin, adriamycinol and their 7deoxyaglycones in human serum by high-performance liquid chromatography, J. Chromatogr, 311, p. 125-133. Don A et.al. (1997), Non ionic surfactant vesicles containing estradiol for topical application. Ph.D. thesis, Centre for drug research, p.330-339. Elias P (1983), Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol, 80, p. 445-495. Fang J et.al. (2001), In-vitro skin permeation of estradiol from various proniosomes formulation, Int J Pharm, 215,p. 91-99. Farkas E. et.al. (2004), Effect of β-sitosterol on the characteristics of vesicular gels containing chlorhexidine, Int.J.Pharm, 278, p. 63-70. Farmer E (Edts) (2000), The Pathology of the skin, McGraw- Hill Health Professions Division, New York, 2nd Edition.
JJT, University
Page 119
Chapter 5
References
Fernandez P. et.al. (2005) Vesicles as rheology modifier, Colloids and Surfaces A: Physicochem. Eng. Aspects, 262, p. 204–210. Finegold S (1992), In: Diagnostic microbiology. 7th ed. London: C.V.Mosby Company, p.176-88. Friberg S et.al. (1985), The influence of solvent on nonaqueous lyotropic liquid crystalline phase formed by triethanolamine oleate, Journal of Pharmceutical Science, 74, p.771–773. Gisby J & Bryant J. (2000), Efficacy of a new cream formulation of Mupirocin: Comparision with oral and topical agents in Experimental skin infections, Antimicrob Agents Chemother, 44, p. 255- 260. Gopinathan M (2002), New Insights into Skin Structure: Scratching the Surface, Adv. Drug Del. Rev., 54 (Supp 1), p. 3-17. Gregoriadis G (1981), Targeting of drugs: implications in medicine. Lancet, 2, 8240, p.241-246 Gupta V (2006), Stability of triamcinolone acetonide solutions as determined by highperformance liquid chromatography, Journal of Pharmaceutical Sciences,72, p. 1453– 1456. Handjani-Vila R.M et.al. (1979), Dispersions of lamellar phases of non-ionic lipids in cosmetic products, Int. J. Cosmetic Sci., 1, p. 303–314. Hannuksela M (1976), Allergy to ingredients of vehicles, Contact Dermatitis 2, p. 105–110. Heather A, Benson E (2005), Transdermal drug delivery: penetration enhancement techniques, Curr. Drug Deli. 2, p. 23-33. Hernandez M et.al. (1998), Rheological characterization of easy to disperse (ETD) carbopol hydrogels, J Disper Sci Tech, 19, p. 31–42.
JJT, University
Page 120
Chapter 5
References
Hu C. and Rhodes D. (1999), Proniosomes: a novel drug carrier preparation, Int. J. Pharm, 185, p. 23-35. Hunter C (1988), Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis, J.Pharm. Pharmacol, 40(3), p.161-165. ICH, Q2 (R1) (2005), Harmonised tripartite guideline Validation of analytical procedures:Text and Methodology International Conference on Harmonization ICH, Geneva, p. 1120. International Conference on Harmonisation (1995), Draft Guideline on Validation of Analytical Procedures: Definitions and Terminology, Federal Register, Volume 60, March 1, p. 11260. Jacob, S.W., Francone, C.A., (Edts.), (1970). Structure and function of man, W. B. Saunders Publishers, Philadelphia, 2nd Edition, Chapter 4. p. 34-47. Jain N.K. (1994), Niosomes as Drug Carriers. Indian Drugs, 31 (3), p. 81-86. Jayaraman C et.al.(1996), Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study, J. Pharm. Sci, 85 (10), p. 1082-1084 Jefferey G et. al. (1989), In: Vogel’s Textbook of quantitative chemical analysis, 5th ed. Longman group U.K. Ltd., England, p.668-712. Jia-You et.al. (2004), Lipid nano/submicron emulsion as a vehicle for topical flurbiprofen delivery, Drug del.,11, p. 97-105. Jia-You F (2004), Lipid nano/submicron emulsion as vehicle for topical flurbiprofen delivery, Drug Del., 11, p. 97-105. Kasapis S (1999), Structural Aspects and phase behaviour in deacylated and high acyl gellan systems, Carbohydrate Polymers, 38, p. 145-154. Katrin M et.al. (2001), Passive skin penetration enhancement and its quantification in vitro, Eur. J. Pharm. And Biopharm, 52, p.103-112 KD Tripathi (1991), Essentials of MEDICAL PHARMACOLOGY 5th Edition P. 716. JJT, University
Page 121
Chapter 5
References
Kenyon A and Layloff T (2002), A Compendium of Unofficial Methods for Rapid Screening of Pharmaceuticals by Thin-Layer Chromatography, Food and Drug Administration Division of Testing and Applied Analytical Development, St. Louis, MO. 63101, p. 104-105 Khamanga S et.al. (2011), Drug transport mechanisms from carbopol/eudragit verapamil sustained-release tablets, Dissolut Technol, 18, p. 30–38. Khandare J et.al. (1994), Niosomes novel drug delivery system, The Eastern Pharmacist, 37, p.61-64. Kincl M and Turk S (2005), Application of experimental design methodology in development and optimization of drug release method, Int J. Pharm, 291, p. 39–49. Kirjavainen M et.al. (1999), Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into bilayers, J. Control. Rel, 58, p. 207-214. Konno K (1974), Solubility, critical aggregating or micellar concentration and aggregate formation of non-ionic surfactants in non-aqueous solutions, Journal of Colloid Interface Science, 49, 383. Lagerquist, C et. al. (1992), Effect of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analyased by immobilized liposomes chromatography. J. Pharm. Pharmacol. 53, p.1477-1487. Lopez-Pinto J et.al. (2005), Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes, Int. J. Pharm., 298, p. 1–12. Malhotra M, Jain N (1991), Niosomes as Drug Carriers, Indian Drugs, 31, p. 81-86. Martin A (1993), Diffusion and Dissolution. In: Physical pharmacy, 4th ed. B. I. Waverly Pvt. Ltd, p.324-61. Maver L et.al. (1985), Biochem Biophys Acta, 816, p. 294-302. Montagna W., (Edt), 1961. The structure and Function of Skin 2nd Edition, Academic Press, New York, 454-470.
JJT, University
Page 122
Chapter 5
References
Mores L (1980), Application of stearates in cosmetic creams and lotions. Cosmet Toilet 95, p. 81–84. Moser P et.al. (1989), Niosomes d'hémoglobine. I. Preparation, proprietes physicochimiques et oxyphoriques, stabilite, Pharma. Acta.Helv, 64 (7), p.192-202. Moussaoui, N et. al. (2002), Note: Marinosomes®, marine lipid based liposomes: physical characterizations and potential applications in cosmetics. 242, p. 361-365. Naik A et.al. (2000), Transdermal drug delivery: overcoming the skin’s barrier function, Elsevier Science Ltd, p. 20-27. Namdeo A et.al. (1999), Formulation and evaluation of niosome encapsulated indomethacin, Indian Drugs, 36(6): p.378-380. Nasseri B, Florence A T. (2003), A vesicular shuttle: transport of a vesicle within a flexible microtube, Journal of Controlled Release, 92, p.233–240. Nystatin on RxList.com http://www.rxlist.com?script/main/srchcont_rxlist Padamwar M (2006), Development of Vitamin loaded topical liposomal formulations using factorial design approach, Int.J.Pharm, p. 74-81. Papahadyopoulos D. (1980), Comparative properties and methods of preparation of lipid vesicles (liposomes), Ann. Rev. Biophys-Bioeng., 9, p.467-508. Papps P & Rex J (2004), Guidelines for treatment of candidiasis. Clin. Infect.Dis, 38, p. 161-189. Parthasarathi G et.al. (1994), Niosome encapsulated of vincristine sulfate: improved anticancer activity with reduced toxicity in mice, J. Drug Target, 2(2), p. 173-182. Provost C (1986), Transperant Oil-water gels, Int J Cosm Sci, 8, p. 233-47. Raja N et.al. (1994), Antiinflammatory activity of Niosome encapsulated diclofenac sodium with Tween -85 in Arthitic rats, Ind.J.Pharmacol, 26, p.46-48. Ralph E (1991), Comparative in vitro effects of liposomal amphotericin B, amphotericin B deoxycholate, and free amphotericin B against fungal strains JJT, University
Page 123
Chapter 5
References
determined by using MIC and minimum lethal concentration susceptibility studies and time-kill curves, Antimicrob. Agents Chemother, 35, p.188-191. Ramsay B et.al. (1990), The effect of triethanolamine application on anthralininduced inflammation and therapeutic effect in psoriasis, Journal of American Acad. Dermatology, 23, p. 73–76. Reddy L (1997), Study of infuence of polymerization factors on formation of poly (butyl cyanoacrylate) nanoparticles and in vitro drug release kinetics. Ars. Pharm, 45, p. 211–234. Rex J et al. (2004), Guidelines for treatment of candidiasis, Clin. Infect.Dis, 38, p. 161-189 Robinson et. al. (1995), Behavior of cholesterol and its effect on head group and chain confirmations in lipid bilayers: a molecular dynamics study. Biophys. J., 68, p. 164-170. Robinson J et al. (1990), Influence of drug properties and route of drug administration on the design of sustain and controlled release system, Controlled drug delivery fundamentals and applications, second edition New York: Marcel Dekker Inc, 29, p. 523-24 Rogerson A et.al. (1988) The distribution of doxorubicin in mice following administration in niosomes, J Pharm Pharmacol, 40(5), p. 337–342. Sarfaraz N. (2004), Skin irritation and sensitization testing of generic transdermal drug products, handbook of pharmaceutical manufacturing formulation: Semisolid product, 4, p.75-76. Schatzelin A and Cevc G. (1998), Non-uniform cellular packing of the stratum corneum and permeability barrier function on intact skin (Transferosomes®), Brit. J. Dermatol, 138, p. 583-592. Scheuplein R (1965), Mechanism of percutaneous absorption: I. Routes of penetrate and the influence of solubility, J. Invest. Dermatol, 45, p. 334-346.
JJT, University
Page 124
Chapter 5
References
Schreier H. (1985), Liposome and niosomes as a topical drug carriers: Dermal and Transdermal delivery, J control release, 30, 863-868. Sethi P. (1993), Quantitative analysis of drug in pharmaceutical formulation, CBS publication, 2, p. 11. Sheskey P et.al. (2006), Cabomer handbook of pharmaceutical excipients 5th Edition. London, UK: Pharmaceutical press, p.111–112. Silver B. (1985), The Physical Chemistry of Membranes, Alan & Unwin and Soloman Press. New York, USA, p.209-230. Skalko N (1992) Liposome with clindamycine hydrochloride in the therapy of acne vulgaris, Int. J. Pharm, 85, p. 97-101. Spiclin P et.al.(2003), Sodium Ascorbyl phosphate in topical micro emulsions, Int. J. Pharm, 256, p. 65-73 Stanley J (1982), Structure and function of basement membrane, J. Invest. Dermatol, 79 (Suppl. 1), p. 695-725. Sternberg B et.al. (1992), Niosomes from Span surfactants: Relations between structure and form, J. Pharm. Pharmcol. Supp,44, p.1044. Suhonen, T et.al, (1999), Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations, J. Control Rel., 59, p. 149-161. Suzuki K. et.al. (1990), The Application of Liposomes to Cosmetics, Cosmetic and Toiletries, 105, 65-78. Tabernera T et.al. (2002),Consistency of Carbopol 971-P NF gels and influence of soluble and cross-linked PVP, Int J Pharm, 233, p. 3–50. Tamburic S (1995), Investigation into the rheological, dielectric and mucoadhesive properties of poly (acrylic acid) gel systems, Journal of Control Release, 37, p. 59–68. Tamburic S et.al. (1995), Rheological evaluation of polyacrylic acid hydrogels, J Pharm Sci., 1, p. 107–109. JJT, University
Page 125
Chapter 5
References
Tamhankar M. et.al. (1995), Niosomes novel drug delivery system, The Eastern Pharmacist, 39, p.84-88. Theresa M (1998), Drugs published by Adis international Ltd., 56 (5), p.747- 756. Thomas J, Schlomer B. (2008), Primary skin irritation test in the rabbit of water gel burn dressing, Available at http://www.waterjel.com/public/Skin irritation Test.pdf. Accesed :Sept20. Uchegbu I. and Vyas S. (1998), Non-ionic Surfactant based vesicles (Niosomes) in drug delivery, Int. J. Pharm., 172, p.33-70. United states Pharmacopoeia (2002), Nystatin. USP-25, NF-20. Rockville: The USP Convention, Inc., p.920. United States Pharmacopoeia (2006), Triamcinolone Acetonide. USP-29, NF-24. Rockville: The USP Convention, Inc, p.2186. Unlu N et.al.(1992), A comparative rheological study on carbopol viscous solutions, Pharm Acta Helv, 67, p. 5–10. Valenta, C (2003). Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids. Int. J. Pharm. 258, p.133-139. Vanhal D. (1996), Diffusion of estradiol from non ionic surfactant vesicles through human stratum corneum in vitro, STP Pharm.Sci., 6, p.72–78. Venkatesh P. et.al.(2000), Niosomal sumatriptan succinate for nasal administration, Int. J. Pharm. Sci., 62(6), p. 479-481. Verma D et.al. (2003), Particle size of liposomes influences dermal delivery of substances into skin, Int. J. Pharm, 258, p.141-151. Vora B. (1998), Proniosome based transdermal delivery of levonorgestrel for effective contraception, J. Control. Rel., 54, p.149–165.
JJT, University
Page 126
Chapter 5
References
Vrhovnik et. al. (1998), Influence of liposome bilayer fluidity on the transport of encapsulated substances into the skin. Pharm. Res., 15, 525–530. Wallace T & Rex J et. al. (2002), In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates. J. Clin. Microbiol, 40, 1406-1412. Wallace T (1997). Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. Antimicrob. Agents Chemother, 41, 22382243. Weissman G (1975), A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells, Proc. Natl. Acad. Sci, 72(1), 88-92. Xia W (2000), Mechanistic Studies on Surfactant- Induced Membrane Permeability Enhancement, Pharmaceutical Research, 17, 612-618. Yalkowsky S, He Y (2003), Handbook of Solubility Data, Boca Raton, FL: CRC Press, p. 1119–1120. Yoshida H et.al. (1992), Niosomes for oral delivery of peptide drugs, J.Control Rel., 21, p.145-153. Yoshioka T. et.al. (1994), Preparation and properties of vesicles (niosomes) of sobitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85), Int J Pharm, 105, p.1-6.
JJT, University
Page 127
